Drug consumption rooms and the role of politics and governance in policy processes

International Journal of Drug Policy

Volumn 25, Issue 5, 2014, Pages 972-977

  Houborg, Esben ^a   Frank, Vibeke Asmussen ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Drug consumption facilities; Drug policy; Governance

Indexed keywords

METHADONE;

ARTICLE; CIVIL DISOBEDIENCE; DECISION MAKING; DRUG CONSUMPTION ROOM; DRUG LEGISLATION; DRUG PROGRAM; DRUG USE; GOVERNMENT REGULATION; HARM REDUCTION; HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LAW ENFORCEMENT; MEDICAL RESEARCH; METHADONE TREATMENT; OPIATE ADDICTION; POLITICAL PARTICIPATION; POLITICAL SYSTEM; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIAL WELFARE; UNITED KINGDOM; DENMARK; DRUG DEPENDENCE TREATMENT; GOVERNMENT; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; ORGANIZATION AND MANAGEMENT; POLITICS; SUBSTANCE-RELATED DISORDERS;

DENMARK; GOVERNMENT; HEALTH POLICY; HUMANS; POLICY MAKING; POLITICS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 84924083949     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.01.008     Document Type: Article

References (50)

1. Asmussen V. Fra fixerum til sundhedsrum-den danske situation og debat?. Nordic Studies on Alcohol and Drugs 2005, 22(1):66-70.
2. Callon M. An essay on framing and overflowing: Economic externalitities revisited by sociology. The laws of the markets 1998, 244-269. Blackwell Publishers/The Sociological Review, Oxford. M. Callon (Ed.).
3. Callon M. Actor-network theory - The market test. Actor network theory and after 1999, 181-195. Blackwell Publishers, Oxford. J. Law (Ed.).
4. Callon M., Méadel C., Rabeharisoa V. The economy of qualities. Economy & Society 2002, 31(2):194-217.
5. Callon M., Lascoumes P., Barthe Y. Acting in an uncertain world. An essay on technical democracy 2009, The MIT Press, Cambridge, MA.
6. Callon M., Rabeharisioa V. The invovement of patients' associations in research. International Social Science Journal 2002, 171:57-65.
7. Callon M., Rabeharisioa V. The growing engagement of emergent concerned groups in political and economic life: Lessons from the french association of neuromuscular disease patients. Science, Technology & Human Values 2008, 33(2):230-261.
8. City Council of Copenhagen Record of Decisions from regular council meeting Thursday Nobember 1st 2001. No 19 BR 424/01 2001, Medlemsforslag om fixerum på Vesterbro.
9. Dolan K., Kimber J., Fry C., Fitzgerald J., McDonald D., Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 2000, 19:337-346.
10. Folketinget Law no. 185, appendix 1, May 7th, Brief about hearing to the health- and prevention committee of Folketinget about proposal to change the Law on Euphoriant Substances (drug consumption rooms) 2012, Sundheds- og forebyggelsesudvalget.
11. Folketinget Law 185 final answer to question 15 2012, Sundheds- og forebyggelsesudvalget.
12. Frank V., Bjerge B., Houborg E. Shifts in opioid substitution treatment policy in Denmark from 2000-2011. Substance Use and Misuse 2013, 48:997-1009.
13. Goffman E. Frame analysis 1974, Northeastern University Press, Boston.
14. Dugnad. Denmarks Problem at Vesterbro 2006, Kommunikationsbureauet Taletid, Copenhagen. N.W. Gotfredsen, M.L. Olsen (Eds.).
15. Hathaway A.D., Tousaw K.I. Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver. International Journal of Drug Policy 2008, 19:11-16.
16. Hedrich D., Kerr T., Dubois-Arber F. Drug consumption facilities in Europe and beyond. Harm reduction: Evidence, impacts and challenges 2012, 305-329. EMCDDA Monograph, Lisbon. T. Rhodes, D. Hedrich (Eds.).
17. Hoff-Lund O., Andersen S., Olsen M.L. The injection room that got wheels 2012, Forlagetpb43, Copenhagen.
18. Houborg E. Stofmisbrug, metadon, subjektivering, Historiske og aktuelle fremstillinger af stofmisbrug 2006, Sociologisk Institut, København.
19. Houborg E. Control and welfare in danish drug policy. Journal of Drug Issues 2010, 40(4):783-804.
20. Houborg E. Regulating intoxication and disciplining pleasure. Pleasure, pain and profit. european perspectives on drugs 2010, 83-100. Pabst Science Publishers, Lengerich. T. Decorte, J. Fountain (Eds.).
21. Houborg E. The political pharmacology of methadone and heroin in danish drug policy. Contemporary Drug Problems 2012, 39(Spring):155-192.
22. Jepsen J. Internationale indflydelser på dansk narkotikapolitik-solidaritet ctr. responsiv ret. Lovens Liv. 2000, 235-256. Jurist- og Økonomforbundets forlag, s, København. C. Henrichsen, A. Storgaard, J. Vedsted-Hansen (Eds.).
23. de Jong W., Weber U. The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy 1999, 10:99-108.
24. Justitsministeriet, Socialministeriet, Sundhedsministeriet Bekæmpelse af Narkotika-misbruget. Elementer og hovedproblemer 1994, Statens Information, København.
25. Jyllandsposten A church needs to be for everybody 2004, 6.
26. Kimber J., Dolan K., Wodak A. Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact. Drug and Alcohol Review 2005, 24:21-24.
27. Kingdon J.W. Agendas, alternatives, and public policies 1995, Harper Collins College Publishers, New York. 1st ed. 1984.
28. Kristeligt Dagblad A place to be 2003.
29. Law no. 185 of June 13th 2012. http://www.retsinfo.dk/.
30. Lloyd C., Hunt N. Drug consumption rooms: An overdue extension to harm reduction policy in the UK?. International Journal of Drug Policy 2007, 18:5-9.
31. Ministry of Finance Agreement on the implementation of special the fund for the social area 2005.
32. van der Poel A., Barendregt C., van de Mheen D. Drug consumption rooms in Rotterdam: An explorative description. European Addiction Research 2003, 9:94-100.
33. Regeringen Kampen mod narko - handlingsplan mod narkotikamisbrug 2003, Indenrigs- og Sundhedsministeriet, København.
34. Rhodes R.A.W. The new governance: Governing without government. Political Studies 1996, XLIV:652-667.
35. Salmon A.M., Dwyer R., Jauncey M., van Beek I., Topp L., Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug and Alcohol Dependence 2008, 101:132-136.
36. Scherbaum N., Specka M., Bombeck J., Marrziniak B. Drug consumption facility as part of a primary health care centre for problem drug users - Which clients are attracted?. International Journal of Drug Policy 2009, 20:447-449.
37. Skretting A. Prøveordning med sprøyterom starter opp i Norge. Nordic Studies on Alcohol and Drugs 2005, 22(1):55-61.
38. Skretting A. The Nordic countries and public drug-injection facilities. Drugs: Education, Prevention and Policy 2006, 13(1):5-16.
39. Small D. Fools rush in where angels fear to tread Playing God with Vancouver's Supervised Injection Facility in the political borderland. International Journal of Drug Policy 2007, 18:18-26.
40. Small W., Rhodes T., Wood E., Kerr T. Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy 2007, 18:27-36.
41. Social Committee of Copenhagen City Council Agenda for regular meeting Wednesday August 16th 2006. Appendix 16: The possibilities of establishing a health room at Vesterbro. Journal no. 309/2006 2006.
42. Stoker Governance as theory: Five propositions. International Social Science Journal 1998, 50(155):17-28.
43. Storgaard L.L. Konstruktionen af dansk narkotikakontrolpolitik siden 1965 2000, Jurist- og økonomforlagets Forlag, København.
44. Stöver H. Consumption rooms - A middle ground between health and public order concerns. Journal of Drug Issues 2002, 32:597-606.
45. Sundhedsstyrelsen Alkohol- og Narkotikamisbruget 1995, Sundhedsstyrelsen, København.
46. Sundhedsstyrelsen Narkoen ud af byen Evaluering af 14 model-kommuneprojekter 2007, Sundhedsstyrelsen, København.
47. Tyndall M.W., Kerr T., Zhang R., King E., Montaner J.G., Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug and Alcohol Dependence 2006, 83:193-198.
48. Watson T.M., Strike C., Kolla G., Penn R., Jairam J., Hopkins S., et al. Design considerations for supervised consumption facilities (SCFs): Preferences for facilities where people can inject and smoke drugs. International Journal of Drug Policy 2013, 24:156-163.
49. Wood E., Kerr T., Tyndall M.W., Montaner J.S.G. The Canadian government's treatment of scientific process and evidence: Inside the evaluation of North America's first supervised injecting facility. International Journal of Drug Policy 2008, 19:220-225.
50. Zurhold H., Degwitz P., Verthein U., Haasen C. Drug consumption rooms in Hamburg, Germany: Evaluation of the effects on harm reduction and the reduction of public nuisance. Journal of Drug Issues 2003, 33:663-688.